| Pfizer AG - Cibinqo 50 mg, Filmtabletten | | 68174 | | 01 | | Cibinqo 50 mg | | Filmtabletten | | D11AH08 | | Abrocitinib | | 06.04.2022 | | |
| | Composition | | abrocitinibum 50 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carboxymethylamylum natricum A corresp. natrium 0.814 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum 1.365 mg, macrogolum 3350, triacetinum, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Abrocitinibum | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Abrocitinibum | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Calcium Hydrogen Phosphate | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 1.365 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| |
|
